ada standards of care 2025 glp-1 dpp-4 combination not recommended guidelines for diabetes treatment Diabetes Standards of Care (2025)

GLP-1 receptor agonists have gained FDA approval for chronic weight management in individuals with obesity or overweight who have at least one weight-related complication

So the path looks indirect

Ozempic is also available as a tablet

Youll want to contact your healthcare provider to find out if you are on the exact right dose for yourself

"I think we should all celebrate and really be delighted by the fact that there are more tools in the toolbox to help people trying to manage their weight." Jennifer VanGilder, a 51-year-old economics professor at Ursinus College in Collegeville, Pennsylvania, said she'd tried countless methods to lose weight, from strict diets to services like the defunct Jenny Craig